Innovative Approaches to Finding
Community Driven Solutions

providing quality research and evaluation services that improve programs that serve vulnerable communities

Creating local capacity

Building in-country research capacity as a strategy to ensure culturally appropriate approaches in research

Now More Than Ever Communities Need Strengthening

Strengthening Communities for an Increasingly Complex World

previous arrow
next arrow
Slider

[wds id=”1″]

[wds id=”2″]

Welcome

GHLiaisons is a division of Global Health Liaisons, LLC. We are professionals dedicated to improving access to services for vulnerable people worldwide, impacting women, children, and minorities. We help organizations build community outreach systems, community development boards, community advisory boards, and supporting the execution of community engagement strategies.  Our team members are innovative, solution-driven, and can help you to build a stronger health education community.

Our mission is to provide innovative solutions that strengthen systems and improve access to services for vulnerable people worldwide.

Our vision is that all people living with limited resources have access to quality services.

MDOT and Office of Minority Business Enterprise EDSWOB Certification No. 19-304

GHLiaisons boasts more than 80 high-quality credentialed professionals experienced working with health and education communities in infectious disease programs, clinical trial management, community advisory board development, community engagement, evaluation, and health systems strengthening in the U.S., Africa, Asia, and the Caribbean.

GHLiaisons’ community engagement experts, clinical trial site specialists, and regulatory reviewers ensure the safety and protection of staff and human subjects in infectious disease clinical trials. Our experience spans more than a dozen countries. Let us help you facilitate community engagement for your next Phase I, II, and III trial. We have subject matter expertise in areas like HIV-1, tuberculosis, oncology, sickle cell, Hep C, cardiovascular disease, malaria, and others too many to mention.

“I very much valued and benefited from your advice and guidance especially in addressing procedural issues which are not always easy. JCRC has a lot to thank you for and many of our staff are in employment and advancing in their careers because of the projects that you helped us win or supported us to sustain.”

~Peter Mugenyi,
Former Director of the Joint Clinical Research Centre in Uganda

If you wish to report a violation of GHLiaisons’ Code of Conduct, please use our Code of Conduct Helpline at codeofconduct@ghliaisons.com.